Rotem Karni

5.9k total citations · 1 hit paper
53 papers, 4.5k citations indexed

About

Rotem Karni is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Rotem Karni has authored 53 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Rotem Karni's work include RNA Research and Splicing (27 papers), RNA modifications and cancer (17 papers) and RNA and protein synthesis mechanisms (13 papers). Rotem Karni is often cited by papers focused on RNA Research and Splicing (27 papers), RNA modifications and cancer (17 papers) and RNA and protein synthesis mechanisms (13 papers). Rotem Karni collaborates with scholars based in Israel, United States and Germany. Rotem Karni's co-authors include Adrian R. Krainer, Rahul Sinha, Scott W. Lowe, David Mu, Alexander Levitzki, Zahava Siegfried, Elisa de Stanchina, Asaf Shilo, Richard Jove and Regina Golan‐Gerstl and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Rotem Karni

53 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The gene encoding the splicing factor SF2/ASF is a proto-oncogene

2007 720 citations Rotem Karni, Adrian R. Krainer et al. Nature Structural & Molecular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rotem Karni Israel	32	3.7k	1.3k	489	442	319	53	4.5k
Jianxiu Yu China	35	2.6k 0.7×	1.2k 0.9×	574 1.2×	408 0.9×	216 0.7×	87	3.3k
Lidija Covic United States	37	1.9k 0.5×	1.2k 0.9×	689 1.4×	487 1.1×	317 1.0×	63	4.8k
Pichai Raman United States	18	1.9k 0.5×	885 0.7×	478 1.0×	429 1.0×	265 0.8×	45	2.9k
B. Nelson Chau United States	24	3.1k 0.8×	1.4k 1.0×	541 1.1×	310 0.7×	193 0.6×	33	4.1k
Narendra Wajapeyee United States	31	2.7k 0.7×	941 0.7×	895 1.8×	553 1.3×	124 0.4×	95	3.7k
Benilde Jiménez Spain	28	2.2k 0.6×	841 0.6×	568 1.2×	356 0.8×	169 0.5×	49	3.1k
Paola Parrella Italy	29	2.3k 0.6×	1.1k 0.8×	773 1.6×	279 0.6×	225 0.7×	79	3.3k
Yaguang Xi United States	34	3.8k 1.0×	3.0k 2.3×	808 1.7×	308 0.7×	197 0.6×	78	4.9k
Jian‐Jun Wei United States	35	2.0k 0.5×	1.1k 0.9×	419 0.9×	588 1.3×	174 0.5×	103	4.1k
Daniela Taverna Italy	39	3.2k 0.9×	1.9k 1.4×	1.1k 2.3×	528 1.2×	152 0.5×	92	4.6k

Countries citing papers authored by Rotem Karni

Since Specialization

Citations

This map shows the geographic impact of Rotem Karni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rotem Karni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rotem Karni more than expected).

Fields of papers citing papers by Rotem Karni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rotem Karni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rotem Karni. The network helps show where Rotem Karni may publish in the future.

Co-authorship network of co-authors of Rotem Karni

This figure shows the co-authorship network connecting the top 25 collaborators of Rotem Karni. A scholar is included among the top collaborators of Rotem Karni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rotem Karni. Rotem Karni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Kuan‐Ting, Chani Stossel, Zahava Siegfried, et al.. (2023). RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer. Nature. 617(7959). 147–153. 55 indexed citations

Cohen, Yuval, et al.. (2023). Inhibition of nonsense-mediated mRNA decay may improve stop codon read-through therapy for Duchenne muscular dystrophy. Human Molecular Genetics. 32(15). 2455–2463. 9 indexed citations

Cohen, Yuval, Georgina D. Barnabas, Zahava Siegfried, et al.. (2022). S6K1 phosphorylates Cdk1 and MSH6 to regulate DNA repair. eLife. 11. 11 indexed citations

Hajaj, Emma, Sharon Merims, Jonathan Cohen, et al.. (2021). Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions. Cancer Immunology Research. 9(6). 637–650. 14 indexed citations

Obiedat, Akram, Amit Rimon, Gordon McLennan, et al.. (2020). Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy. Nature Communications. 11(1). 1304–1304. 45 indexed citations

Goldman‐Wohl, Debra, et al.. (2020). Trophoblast lineage specific expression of the alternative splicing factor RBFOX2 suggests a role in placental development. Placenta. 100. 142–149. 4 indexed citations

Malakar, Pushkar, Ilan Stein, Amijai Saragovi, et al.. (2019). Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2. Cancer Research. 79(10). 2480–2493. 140 indexed citations

Shilo, Asaf, Shaya Lev, Maxim Mogilevsky, et al.. (2019). 2-APB and CBD-Mediated Targeting of Charged Cytotoxic Compounds Into Tumor Cells Suggests the Involvement of TRPV2 Channels. Frontiers in Pharmacology. 10. 1198–1198. 19 indexed citations

Gershkovitz, Maya, Yaki Caspi, Tanya Fainsod-Levi, et al.. (2018). TRPM2 Mediates Neutrophil Killing of Disseminated Tumor Cells. Cancer Research. 78(10). 2680–2690. 165 indexed citations

10.

Malakar, Pushkar, Asaf Shilo, Ilan Stein, et al.. (2016). Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation. Cancer Research. 77(5). 1155–1167. 259 indexed citations

11.

Lamm, Noa, Assaf C. Bester, Michael M. Im, et al.. (2015). Folate levels modulate oncogene‐induced replication stress and tumorigenicity. EMBO Molecular Medicine. 7(9). 1138–1152. 28 indexed citations

12.

Shilo, Asaf, Ilan Stein, Eli Pikarsky, et al.. (2014). Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development. RNA. 20(4). 505–515. 86 indexed citations

13.

Siegfried, Zahava, Serena Bonomi, Claudia Ghigna, & Rotem Karni. (2013). Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer. International Journal of Cell Biology. 2013. 1–9. 39 indexed citations

14.

Lebenthal-Loinger, Ilana, et al.. (2013). RRM1 domain of the splicing oncoprotein SRSF1 is required for MEK1-MAPK-ERK activation and cellular transformation. Carcinogenesis. 34(11). 2498–2504. 36 indexed citations

15.

Golan‐Gerstl, Regina, et al.. (2012). Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer. Clinical & Experimental Metastasis. 30(1). 103–117. 20 indexed citations

16.

Anczuków, Olga, Avi Z. Rosenberg, Martin Akerman, et al.. (2012). The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nature Structural & Molecular Biology. 19(2). 220–228. 330 indexed citations

17.

Golan‐Gerstl, Regina, Michal Cohen, Asaf Shilo, et al.. (2011). Splicing Factor hnRNP A2/B1 Regulates Tumor Suppressor Gene Splicing and Is an Oncogenic Driver in Glioblastoma. Cancer Research. 71(13). 4464–4472. 193 indexed citations

18.

Karni, Rotem, et al.. (2007). Subunit S5a of the 26S proteasome is regulated by antiapoptotic signals. FEBS Journal. 274(11). 2815–2831. 8 indexed citations

19.

Karni, Rotem, et al.. (2003). The pp60^c‐Src inhibitor PP1 is non‐competitive against ATP. FEBS Letters. 537(1-3). 47–52. 69 indexed citations

20.

Karni, Rotem, Yuval Dor, Eli Keshet, Oded Meyuhas, & Alexander Levitzki. (2002). Activated pp60c-Src Leads to Elevated Hypoxia-inducible Factor (HIF)-1α Expression under Normoxia. Journal of Biological Chemistry. 277(45). 42919–42925. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact